30 Day Trial

TheraCell Announces Milestone Delivery of >12,000 of its Licensed Bone Grafts

Share:

TheraCell announced that over 12,000 of its novel demineralized bone fiber products have been delivered to date, primarily for use in spinal fusions.

TheraCell's next-generation production process allows for controlled geometry fibers with very high consistency and fiber yields, with cell-friendly nanotopography that allows fibers to generate a broad line of procedure-specific products, such as TheraCell Fiber Boats and TheraFuze DBF®, pictured below.

The company is launching a comprehensive portfolio of TheraFuze DBF graft products later this month, including the TheraFuze DBF Fiber Anchor™ for immediate enhanced screw fixation, particularly in compromised bone; TheraFuze DBF Fiber Bullets™ for delivery through a cannula in minimally invasive surgery cases; the TheraFuze DBF Fiber Wrap™ for graft containment and a 3-level TheraFuze DBF Fiber Boat. 

TheraCell TheraFuze DBF - ORTHOWORLD

Source: TheraCell, Inc.